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Abstract
Background: The functional and structural characterisation of enzymes that belong to microbial metabolic
pathways is very important for structure-based drug design. The main interest in studying shikimate pathway
enzymes involves the fact that they are essential for bacteria but do not occur in humans, making them selective
targets for design of drugs that do not directly impact humans.
Description: The ShiKimate Pathway DataBase (SKPDB) is a relational database applied to the study of shikimate
pathway enzymes in microorganisms and plants. The current database is updated regularly with the addition of
new data; there are currently 8902 enzymes of the shikimate pathway from different sources. The database
contains extensive information on each enzyme, including detailed descriptions about sequence, references, and
structural and functional studies. All files (primary sequence, atomic coordinates and quality scores) are available for
downloading. The modeled structures can be viewed using the Jmol program.
Conclusions: The SKPDB provides a large number of structural models to be used in docking simulations, virtual
screening initiatives and drug design. It is freely accessible at http://lsbzix.rc.unesp.br/skpdb/.
Background
The functional and structural characterisation of
enzymes belonging to microbial metabolic pathways is
very important for structure-based drug design [1]. The
main interest in the study of shikimate pathway enzymes
(Figure 1) involves the fact that they are not present in
humans, but are essential for algae, higher plants, bac-
teria, fungi, and apicomplexan parasites. This makes
them attractive targets for development of new antimi-
crobial drugs and decreases the impact of drugs in
humans [2,3].
This pathway links the metabolism of carbohydrates to
the biosynthesis of aromatic compounds through seven
metabolic steps, where phosphoenolpyruvate (PEP) and
erythrose 4-phosphate are converted to chorismate,
which in turn is the common precursor for synthesising
a series of aromatic compounds, naphtoquinones, mena-
quinones, and mycobactins [3,4].
Inhibition of the shikimate pathway has been effective
in controlling bacterial growth [5], and in mycobacteria,
this pathway has been shown to be essential for the via-
bility of Mycobacterium tuberculosis [6-8].
The functional and structural characterisation of a pro-
tein sequence is one of the most frequent problems in
structural molecular biology. This task is usually facili-
tated by an accurate three-dimensional (3D) structure of
the studied protein, which is best determined by experi-
mental methods such as X-ray crystallography and NMR
spectroscopy [9]. In the absence of an experimentally
determined 3D structure, the modeling (comparative or
by homology) can sometimes provide a useful 3D model
for a target protein [10]. In the present work, we used
comparative modeling at a large scale for predicting pro-
tein structures through the program MODELLER [11].
The automation of large-scale comparative modeling
involves assembling a software pipeline, which consists
of modules for fold assignment, template selection, tar-
get-template alignment, model generation, and model
evaluation. Computer programs for these individual
operations already exist, and it may seem trivial to com-
bine them [11,12]. One example of large-scale
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described for sequences encoded in the Mycobacterium
tuberculosis and Xylella fastidiosa genomes in the
DBMODELING database [13,14]. The challenge in large-
scale comparative modeling is to build an automated,
fast, robust, sensitive, and accurate pipeline applicable to
whole genomes; such a pipeline should perform at least
as well as a human expert on individual proteins.
However, since the accuracy of structural models is
highly dependent on sequence identity between template
and target, it is necessary to make clear to the user that
only models presenting high structural quality should be
used in such efforts. Molecular modeling of these
enzymes generated the SKPDB database, in which all
structural models were built by using alignments pre-
senting more than 30% sequence identity, generating
models with medium and high accuracy [10,15].
SKPDB is a relational database of protein structure
predicted by comparative modeling or solved by X-ray
crystallography, applied to the study of shikimate path-
way enzymes of microorganisms and plants. This data-
base is freely accessible for all users on the Web,
providing us with a large number of structural models
for use in structure-based virtual screening and molecu-
lar docking analysis. Furthermore, SKPDB also provides
a docking interface, which allows the user to carry out
geometric docking simulations against the molecular
models available in the database.
Construction and Content
Molecular modeling in large scale
Homology modeling is usually the method of choice
when there is a clear relationship of homology between
the sequences of a target protein and at least one
experimentally determined three-dimensional structure.
This computational technique is based on the assump-
tion that tertiary structures of two proteins will be simi-
lar if their sequences are related, and it is the approach
most likely to give accurate results [16].
The number of protein sequences that can be modeled
and the accuracy of the predictions are increasing steadily
due to the growth in the number of experimentally deter-
mined protein structures and because of the improve-
ments in the modeling software. It is currently possible to
model with useful accuracy significant parts of approxi-
mately one half of all known protein sequences [17].
The molecular modeling in this work was performed
by the MODELLER version 9v4 [10,18] program, which
is a computer program for comparative protein struc-
ture modeling http://salilab.org/modeller. The program
extracts atom-atom distance and dihedral angle
restraints on the target from the template structure, and
combines them with general rules of protein structure
such as bond length and angle preferences. The model
is then calculated by an optimisation procedure that
minimises violations of the spatial restraints [11]. In the
simplest case, the input is an alignment of a sequence to
be modeled with the template structures, the atomic
coordinates of the templates and a short script file.
MODELLER then automatically calculates a model con-
taining all non-hydrogen atoms, without any user inter-
vention and within minutes on a processor [19].
The MODELLER program was completely automated
to calculate comparative models for a large number of
protein sequences, by using many different template
structures and sequence-structure alignments [12,16,17].
Sequence-structure matches are established by aligning
SALIGN [20] sequence profile of the target sequence
against each of the template sequences extracted from
PDB [21]. Significant alignments covering distinct
regions of the target sequence are chosen for modeling.
Models are calculated for each one of the sequence-
structure matches by using MODELLER [11]. The mod-
els consist of coordinates for all non-hydrogen atoms in
the modeled part of a protein [16]. For each enzyme in the
SKPDB, a total of 1000 models were generated and the
final models were selected based on stereochemical quality
Figure 1 The sequence of seven metabolic steps in the
shikimate pathway, from phosphoenolpyruvate and erythrose
4-phosphate to chorismate, adapted from the site: http://www.
chem.qmul.ac.uk/iubmb/enzyme/reaction/misc/shikim.html.
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were then evaluated by composite model quality criteria
(see topic Analysis tools).
The MODELLER program was parallelised on a Beo-
wulf cluster with 16 nodes (AMD Athlon 2100+ Bio-
Comp. São José do Rio Preto, SP, Brazil). It controls the
distribution of the MODELLER jobs on the Beowulf
cluster using a C language library, message passing
interface (MPI). It allows parallel MODELLER execution
and decreases the processing time of the modeling pro-
cess. Figure 2 shows a schematic drawing of automated
comparative modeling in large scale used in the model-
ing process for SKPDB.
Analysis tools
Difficult cases in homology modeling correspond to pro-
tein sequences that only possess distant homologues of
known structure. In such cases, incorrect alignment can
lead to regions of a model that have significant struc-
tural errors. The quality of the predicted model deter-
mines the information that can be extracted from it.
Thus, estimating the accuracy of 3D protein models is
essential for interpreting them. The model can be evalu-
ated as a whole as well as in the individual regions [13].
The overall stereochemical quality and the evaluation
of the final model were performed by the programs
PROCHECK [22] and WHATCHECK. These programs
were used to check bond lengths, bond angles, peptide
bonds and side-chain ring planarities, chirality, main-
chain and side-chain torsion angles. Another quality
score used in the analysis of the structural model was
the G-factor, which is essentially just a log-odds score
based on the observed distributions of the stereochemi-
cal parameters performed by the program PROCHECK
[22]. The root mean square deviations (RMSD) from
ideal geometries for bond lengths, bond angles, dihedrals
and impropers were extracted for each model by using
the program X-PLOR [23], and the program VERIFY-
3D was used to measure the compatibility of a protein
model with its sequence by using a 3D profile [24,25].
These programs were used to assess the quality of the
available models and can be accessed by any user in the
SKPDB web page for each enzyme.
Web SKPDB platform
The SKPDB is implemented on Apache server 2 http://
apache.org/ with Fedora 9 http://fedoraproject.org/ as
an operating system. The MySQL server version 4.0.20
http://www.mysql.com is used in SKPDB to store,
retrieve and manage the data. All scripts for data query-
ing and retrieving were written in PERL/CGI version
5.8.4 http://www.perl.com/, and JAVA http://java.sun.
com. The web interfaces are designed using HTML lan-
g u a g ew i t hs o m es c r i p t si nJ a v a S c r i p t ,a n dt h e yr e l yo n
Cascading Style Sheet (CSS) support. The modeled
structures can be viewed with Jmol http://jmol.source-
forge.net/, which is an open source software suite.
Results are displayed in html format.
Data Source
All entries in SKPDB were sourced from Swiss-Prot/
UniprotKB [26] protein sequence database and PDB
[21] protein structure database. Initially, exhaustive
queries were made to Swiss-Prot/UniprotKB, returning
more than 10.000 enzymes of shikimate pathways from
different organisms. The process of building SKPDB is
shown in figure 3. The enzyme data were then filtered
to exclude redundancy, errors, and incomplete data.
Then the data were included into a single composite
non-redundant database.
Figure 2 The flowchart describing all steps of comparative
modeling in large scale, used in the model predictions for
SKPDB, adapted from [27].
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pathway from microorganisms and plants. The majority
of the protein structures (5477 entries) were predicted by
comparative modeling, though the database also includes
53 protein structures solved by crystallography and 3372
proteins without any structure solved/modeled.
SKPDB description
SKPDB is a relational database of protein structures pre-
dicted by comparative modeling or solved by crystallo-
graphy, applied to the study of shikimate pathway
enzymes. Each entry in SKPDB provides information
about a given enzyme, including: (1) a detailed descrip-
tion of the enzyme, (2) the primary sequence of the
enzyme, (3) the structure model of the enzyme, (4) the
chemical properties of the enzyme, (5) references about
the enzyme, and (6) comments and miscellaneous infor-
mation. All files (primary sequence, atomic coordinates
and quality values) are available for downloading. This
database is available for all users on the Web, providing
a large amount of structural models to be used in virtual
screening initiatives and molecular docking.
T h eS K P D Bi sr e g u l a r l yu p d a t e dw i t ht h ea d d i t i o no f
new data and tools about shikimate pathway enzymes.
A click on the links opens a new window that displays
more detailed information for the selected enzyme, in dif-
ferent biological databases such as Swiss-Prot/UniprotKB,
PDB, KEGG, BRENDA, IUMB, and PUBMED, among
others. The enzyme records page contains primary
sequence and structure of the model, information about
alignment, analysis of target models such as PROCHECK,
G-factor and the values of the RMSD from ideal geometry.
Description table content in SKPDB
For data storing, a database was built that contained the fol-
lowing tables: sequence, model, template and analysis. The
data were included in the tables through the scripts in Perl
and the use of language specific modules (DBD:: mysql) that
allow for interaction with the database, as shown in figure 4.
The database is queried from an html client using Perl-CGI
programming, which displays the records as dynamically
generated web pages in different frames.
Utility and Discussion
How to use the SKPDB?
T h eS K P D Bp r o v i d e saf r i e n d l yi n t e r f a c ew i t ham e n u
and detailed help page for the searched function. In the
menu on the left side of the homepage of SKPDB
(Figure 5), users can find several information sources
about the metabolic pathway of the shikimate pathway,
with details about each enzyme (function, chemical struc-
ture, binding site, etc) displayed in figure 6. In addition,
information about members of the group and contact
details (an email for suggestions, criticisms and possible
errors that the database might present) are provided.
Figure 3 The construction of the SKPDB database.
Figure 4 This diagram describes the entity relationships for
database tables.
Figure 5 Homepage of SKPDB.
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The homepage offers to the user different ways for
searching the database (Figure 5). The user can search
in the SKPDB for a specific enzyme, just by using the
Swiss-Prot+UniprotKB access number code. SKPDB also
can be searched using the field “organism” or “name of
enzyme”, or even using a combination of both fields.
A query is formed by selecting one radio button, and
the blank text forms are entered with keywords or
strings, such as a partial or full name of the enzyme or
organism.
The HTML form parses the criteria into SQL database
queries. The initial results re t u r n e da r ef o r m a t t e di n t oa
summary table as described above (Figure 7). Selecting
the access number of an enzyme in the summary table
opens a new window displaying detailed information for
the enzyme (Figure 8), if the structure was solved by
molecular modeling. However, if the enzyme was resolved
by NMR or crystallography, a page with information
about the primary sequence and experimental data with
external links to the PDB will be displayed (Figure 9).
When there is neither an experimentally determined
structure nor templates to generate the homology
model, a warning message is given.
Output data
Output is generated in an html page too. The tab
“Sequence Info” displays general information about the
enzyme such as molecular weight, organism, taxonomy,
size of the enzyme (aa), a download of the primary
sequence, and a link to the Swiss-Prot+UniprotKB to
increase accessibility to other types of information on
the enzyme (Figure 8).
The tab “Model Info” has information about model
predicted by molecular modeling, such as the template
Figure 6 The page for the shikimate pathway.
Figure 7 This page is shown when the user searches by name
of enzyme, or by organism, or by name of enzyme AND
organism.
Figure 8 The resulting page when the structure of the enzyme
was predicted by molecular modeling.
Figure 9 The resulting page when the structure of the enzyme
was experimentally determined.
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PDB) and the alignment (identity, similarity, and gaps
score) between the primary sequences (target/template)
and structure that can be viewed through Jmol. By
default, structures in SKPDB are displayed as ribbons
coloured by secondary structure. After loading, the user
has several options that control the display of structure,
selection of atoms and presentation styles. Users can
also zoom in, zoom out, move and rotate the structure,
or change the colour of the background. An example
visualisation of the structure is shown in Figure 10.
Information about template, organism, experimental
method, resolution (if any) and, publication (if any -
a u t h o r ,j o u r n a l ,t i t l e ,v o l u m e ,p a g e ,y e a ra n dl i n kt o
external access to PUBMED) are displayed in a tab
called “Template Info”, as shown in Figure 11.
Figure 12 shows the tab “Model Analysis” that pre-
sents the analysis of the models available dynamically in
relation to the results of the generated model. This
analysis provides web reports and charts of analysis of
the chemical environment of the protein in addition to
an analysis of the angles  and ψ, establishes the posi-
tion of the angles of twisting in the protein chain,
checks possible stereochemical clashes between the side
chains of atoms (PROCHECK and G Factor), and finally
calculates the value of the RMSD from ideal geometry.
All external links in SKPDB provide additional informa-
tion with respect to the primary sequence and structural
and functional annotations of the enzymes.
Conclusions
Large scale protein homology modeling, in which whole
sequence databases or whole genomes are used as
inputs into automated modeling algorithms, has been
reported by several groups [14,27]. By utilising powerful
computer systems with multiple processors, these efforts
have allowed the creation of large databases of homol-
ogy models of proteins. This work resulted in the devel-
opment of SKPDB, which is a useful tool in structural
biology that provides annotating sequence information
that contributes to structural biology and functional stu-
dies of shikimate pathway enzymes for drug develop-
ment purposes. If a 3D model of the protein of interest
can be derived, it may be usable as the basis for a struc-
ture-based drug-design study. In addition to this, such
models can also be useful to the rational design of
experiments such as site-directed mutagenesis.
Availability and requirements
Project Home Page: http://lsbzix.rc.unesp.br/skpdb
Operating Systems: Linux Fedora
License: the SKPDB is publically accessible viacite
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